NO20065061L - Benzoksazin for behandling av sykdommer i luftveiene - Google Patents

Benzoksazin for behandling av sykdommer i luftveiene

Info

Publication number
NO20065061L
NO20065061L NO20065061A NO20065061A NO20065061L NO 20065061 L NO20065061 L NO 20065061L NO 20065061 A NO20065061 A NO 20065061A NO 20065061 A NO20065061 A NO 20065061A NO 20065061 L NO20065061 L NO 20065061L
Authority
NO
Norway
Prior art keywords
treatment
benzoxazine
respiratory diseases
rog
medicament
Prior art date
Application number
NO20065061A
Other languages
English (en)
Norwegian (no)
Inventor
Kurt Schromm
Christoph Hoenke
Andreas Schnapp
Klaus Rudolf
Ingo Konetzki
Sabine Pestel
Frank Buettner
Hermann Schollenberger
Claudia Heine
Philipp Lustenberger
Thierry Bouyssou
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20065061L publication Critical patent/NO20065061L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20065061A 2004-04-22 2006-11-02 Benzoksazin for behandling av sykdommer i luftveiene NO20065061L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
PCT/EP2005/004075 WO2005102350A1 (de) 2004-04-22 2005-04-18 Benzoxazine zur behandlung von atemwegserkrankungen

Publications (1)

Publication Number Publication Date
NO20065061L true NO20065061L (no) 2006-11-07

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065061A NO20065061L (no) 2004-04-22 2006-11-02 Benzoksazin for behandling av sykdommer i luftveiene

Country Status (20)

Country Link
EP (1) EP1765355B1 (da)
JP (1) JP2007533684A (da)
KR (2) KR20130042662A (da)
CN (1) CN1946406A (da)
AU (1) AU2005235420C1 (da)
BR (1) BRPI0510084A (da)
CA (1) CA2559700C (da)
DE (1) DE102004019539A1 (da)
DK (1) DK1765355T3 (da)
EA (1) EA012045B1 (da)
EC (1) ECSP066948A (da)
ES (1) ES2403184T3 (da)
IL (1) IL177663A (da)
NO (1) NO20065061L (da)
NZ (1) NZ551272A (da)
PL (1) PL1765355T3 (da)
SG (1) SG152233A1 (da)
UA (1) UA85707C2 (da)
WO (1) WO2005102350A1 (da)
ZA (1) ZA200606547B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
BRPI0614410A2 (pt) 2005-08-15 2011-03-29 Boehringer Ingelheim Int processo para preparação de betamiméticos
KR20080067699A (ko) * 2005-11-09 2008-07-21 베링거 인겔하임 인터내셔날 게엠베하 흡입용 에어로졸 제형
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
AU2009203693B2 (en) 2008-01-11 2012-06-07 Novartis Ag Pyrimidines as kinase inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
MA34969B1 (fr) 2011-02-25 2014-03-01 Irm Llc Composes et compositions en tant qu inibiteurs de trk
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
JP2019536812A (ja) 2016-12-12 2019-12-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング オロダテロールとの同時投与による間質性肺疾患の処置方法に使用するためのニンテダニブ
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
EP4651867A1 (en) 2023-01-20 2025-11-26 Atrogi AB Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
SK15382002A3 (sk) * 2000-04-27 2003-03-04 Boehringer Ingelheim Pharma Kg Betamimetiká, farmaceutický prostriedok s ich obsahom a ich použitie
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
ECSP066948A (es) 2006-12-20
ES2403184T3 (es) 2013-05-16
ZA200606547B (en) 2008-04-30
CA2559700C (en) 2013-06-11
DK1765355T3 (da) 2013-04-08
SG152233A1 (en) 2009-05-29
UA85707C2 (ru) 2009-02-25
NZ551272A (en) 2010-10-29
EA200601837A1 (ru) 2007-04-27
IL177663A (en) 2014-04-30
EP1765355A1 (de) 2007-03-28
AU2005235420C1 (en) 2011-02-24
KR101338947B1 (ko) 2013-12-10
DE102004019539A1 (de) 2005-11-10
EA012045B1 (ru) 2009-08-28
CN1946406A (zh) 2007-04-11
BRPI0510084A (pt) 2007-10-16
AU2005235420B2 (en) 2010-10-28
KR20070054599A (ko) 2007-05-29
EP1765355B1 (de) 2013-03-06
JP2007533684A (ja) 2007-11-22
AU2005235420A1 (en) 2005-11-03
PL1765355T3 (pl) 2013-08-30
IL177663A0 (en) 2006-12-31
KR20130042662A (ko) 2013-04-26
WO2005102350A1 (de) 2005-11-03
CA2559700A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
NO20065061L (no) Benzoksazin for behandling av sykdommer i luftveiene
NO20082496L (no) Pyrazinderivater
ATE369353T1 (de) Medizinisch verwendbare arylethanolamin verbindungen
DE60318193D1 (en) Phenethanolaminderivate
HRP20050432A2 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
GEP20084439B (en) Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
WO2002055496A8 (en) Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
GB0112348D0 (en) Compounds
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20062983L (no) Sulfonamid-derivater for behandling av sykdommer
NO20084328L (no) Nye forbindelser
SI1696905T1 (sl) Substituirani 2-aminotetralini za preventivno zdravljenje Parkinsonove bolezni
PL2081910T3 (pl) Nowe związki
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
NO20073170L (no) Kaspaseinhibitorer og anvendelse derav
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
DK1641454T3 (da) Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere
NO20073176L (no) Nye medikamenter for behandling av luftveissykdommer
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
MX2011011618A (es) Agentes terapeuticos 713.
EA200602016A1 (ru) ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ
WO2008043788A3 (en) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application